Fatty acid synthase expression is strongly related to menopause in early-stage breast cancer patients

Menopause

Volumn 21, Issue 2, 2014, Pages 188-191

  Porta, Rut ^a,b   Blancafort, Adriana ^b   Casòliva, Gemma ^c   Casas, Miquel ^d   Dorca, Joan ^a   Buxo, Maria ^a   Viñas, Gemma ^a,b   Oliveras, Glòria ^a,b   Puig, Teresa ^b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c Dementia Unit   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Breast cancer; Early stage; Fatty acid synthase; Menopause

Indexed keywords

ADULT; AGED; BODY FAT DISTRIBUTION; BODY MASS INDEX; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CROSS-SECTIONAL STUDIES; FATTY ACID SYNTHASE, TYPE I; FEMALE; GENE EXPRESSION; HUMANS; MENOPAUSE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; SPAIN;

EID: 84895076898     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31829d17dc     Document Type: Article

References (32)

1. Smith S. The animal fatty acid synthase: One gene, one polypeptide, seven enzymes. FASEB J 1994;8:1248-1259.
2. Kuhajda FP. Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition 2000;16:202-208.
3. Kuhajda FP. Fatty acid synthase and cancer: New application of an old pathway. Cancer Res 2006;66:5977-5980.
4. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-777.
5. Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997;3:2115-2120.
6. Swinnen JV, Roskams T, Joniau S, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002;98:19-22.
7. Piyathilake CJ, Frost AR, Manne U, et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 2000;31:1068-1073.
8. Puig T, Vazquez-Martin A, Relat J, et al. Fatty acid metabolism in breast cancer cells: Differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. Breast Cancer Res Treat 2008;109:471-479.
9. Puig T, Colomer R, Brunet J, et al. Novel polyhydroxylated compounds as fatty acid synthase (FASN) inhibitors. Patent PCT/ES2008/058099, 2007.
10. Puig T, Porta R, Colomer R. [Fatty acid synthase: A new anti-tumor target]. Med Clin 2009;132:359-363.
11. Puig T, Turrado C, Benhamu B, et al. Novel inhibitors of fatty acid synthase with anticancer activity. Clin Cancer Res 2009;15:7608-7615.
12. Brusselmans K, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int J Cancer 2003;106:856-862.
13. Carvalho MA, Zecchin KG, Seguin F, et al. Fatty acid synthase inhibition with orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int J Cancer 2008;123: 2557-2565.
14. Lee JS, Sul JY, Park JB, et al. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBr3 human breast cancer cells. Phytother Res 2012;27:713-720.
15. Vazquez-Martin A, Ropero S, Brunet J, et al. Inhibition of fatty acid synthase (FASN) synergistically enhances the efficacy of 5-fluoracil in breast carcinoma cells. Oncol Rep 2007;18:973-980.
16. Puig T, Aguilar H, Cufi S, et al. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines. Breast Cancer Res 2011;13:R131.
17. Orita H, Coulter J, Lemmon C, et al. Selective inhibition of fatty acid synthase for lung cancer treatment. Clin Cancer Res 2007;13:7139-7145.
18. Alo PL, Visca P, Trombetta G, et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999; 85:35-40.
19. Nakamura I, Kimijima I, Zhang GJ, et al. Fatty acid synthase expression in Japanese breast carcinoma patients. Int J Mol Med 1999;4:381-387.
20. Gansler TS, Hardman W, Hunt DA, et al. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 1997;28:686-692.
21. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 1996;27:917-921.
22. Notarnicola M, Tutino V, Calvani M, et al. Serum levels of fatty acid synthase in colorectal cancer patients are associated with tumor stage. J Gastrointest Cancer 2012;43:508-511.
23. Vazquez-Martin A, Fernandez-Real JM, Oliveras-Ferraros C, et al. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int J Oncol 2009;35:1369-1376.
24. Li H, Yang G, Xiang YB, et al. Body weight, fat distribution and colorectal cancer risk: A report from cohort studies of 134 255 Chinese men and women [epub ahead of print]. Int J Obes 2012.
25. Yang TY, Cairns BJ, Allen N, et al. Postmenopausal endometrial cancer risk and body size in early life and middle age: Prospective cohort study. Br J Cancer 2012;107:169-175.
26. Lundholm L, Zang H, Hirschberg AL, et al. Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 2008;90:44-48.
27. Stahl MS, Prichard J, Stark A. Adiposity and risk of proliferative diseases of the breast prior to the diagnosis of invasive breast cancer: Results from a pilot study. Breast J 2012;18:191-194.
28. Alo PL, Visca P, Marci A, et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 1996;77:474-482.
29. Chalbos D, Escot C, Joyeux C, et al. Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J Natl Cancer Inst 1990;82:602-606.
30. Ley CJ, Lees B, Stevenson JC. Sex-and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992;55:950-954.
31. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
32. Tsuji T, Yoshinaga M, Togami S, et al. Fatty acid synthase expression and clinicopathological findings in endometrial cancer. Acta Obstet Gynecol Scand 2004;83:586-590.